Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein, Y-linked (PRORY, CYorf17) is a gene situated on the human Y chromosome, encoding a transcript classified as a long non-coding RNA (lncRNA)[2][6]. Long non-coding RNAs are RNA molecules exceeding 200 nucleotides that do not encode proteins but commonly function in regulatory roles, affecting gene expression, chromatin structure, or RNA splicing[1][3][5]. PRORY is annotated in transcriptomics and gene-expression databases but remains poorly characterized, with limited functional or disease-related data available[2][6]. It is distinct in being Y-linked, suggesting male-specific expression, but specific biological functions, disease associations, or drug interactions have not yet been established. If you require structured data, the current body of evidence does not support inclusion of PRORY as a traditional therapeutic target, nor does it associate it with pharmacological modulation or clinical biomarker status. It is best categorized as a Y-linked, proline-rich, long non-coding RNA with basic annotation data and no documented links to drug therapy or disease mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein, Y-linked (PRORY).